GB1454105A - Preparation containing luteinizing hormone-releasing factor - Google Patents
Preparation containing luteinizing hormone-releasing factorInfo
- Publication number
- GB1454105A GB1454105A GB5132473A GB5132473A GB1454105A GB 1454105 A GB1454105 A GB 1454105A GB 5132473 A GB5132473 A GB 5132473A GB 5132473 A GB5132473 A GB 5132473A GB 1454105 A GB1454105 A GB 1454105A
- Authority
- GB
- United Kingdom
- Prior art keywords
- releasing factor
- preparation containing
- luteinizing hormone
- nov
- hormone releasing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Reproductive Health (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
1454105 Compositions comprising luteinising hormone releasing factor HOECHST AG 5 Nov 1973 [4 Nov 1972 (2)] 51324/73 Heading A5B The invention comprises pharmaceutical compositions for intranasal application containing luteinising hormone releasing factor and having a viscosity of at least 30 cp at 20‹C. They may be in such forms as ointments, oily suspensions (which may be packaged with a propellant under pressure) and isotonic aqueous solutions comprising conventional diluents and excipients. The active substance is stated to be a decapeptide of formula:
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2254061A DE2254061A1 (en) | 1972-11-04 | 1972-11-04 | LH-RELEASING HORMONE FOR NASAL APPLICATION |
DE2254043A DE2254043C2 (en) | 1972-11-04 | 1972-11-04 | LH-releasing hormone for nasal application |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1454105A true GB1454105A (en) | 1976-10-27 |
Family
ID=25764050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5132473A Expired GB1454105A (en) | 1972-11-04 | 1973-11-05 | Preparation containing luteinizing hormone-releasing factor |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1454105A (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2400904A1 (en) * | 1977-08-24 | 1979-03-23 | Takeda Chemical Industries Ltd | PREPARATIONS FOR VAGINAL ADMINISTRATION AND THEIR USE AS AGENTS CAUSING OVULATION OR AS ANTI-MITOTIC AGENTS |
EP0111841A1 (en) * | 1982-12-10 | 1984-06-27 | Syntex (U.S.A.) Inc. | LHRH preparations for intranasal administration |
US4476116A (en) * | 1982-12-10 | 1984-10-09 | Syntex (U.S.A.) Inc. | Polypeptides/chelating agent nasal compositions having enhanced peptide absorption |
US4897256A (en) * | 1986-11-25 | 1990-01-30 | Abbott Laboratories | LHRH analog formulations |
US4985404A (en) * | 1984-10-04 | 1991-01-15 | Monsanto Company | Prolonged release of biologically active polypeptides |
US5013713A (en) * | 1984-10-04 | 1991-05-07 | Monsanto Company | Prolonged release of biologically active somatotropin |
US5086041A (en) * | 1984-10-04 | 1992-02-04 | Monsanto Company | Methods of using prolonged release somatotropin compositions |
US5116817A (en) * | 1982-12-10 | 1992-05-26 | Syntex (U.S.A.) Inc. | LHRH preparations for intranasal administration |
FR2673635A1 (en) * | 1990-11-09 | 1992-09-11 | Egyt Gyogyszervegyeszeti Gyar | PROCESS FOR THE PREPARATION OF AEROSOL COMPOSITION |
US5411951A (en) * | 1984-10-04 | 1995-05-02 | Monsanto Company | Prolonged release of biologically active somatotropin |
US5474980A (en) * | 1984-10-04 | 1995-12-12 | Monsanto Company | Prolonged release of biologically active somatotropins |
US5618786A (en) * | 1987-04-30 | 1997-04-08 | Cooper Laboratories, Inc. | Aerosolization of protein therapeutic agent |
CN1109558C (en) * | 1993-06-29 | 2003-05-28 | 凡林有限公司 | Stabilized pharmaceutical peptide compositions |
-
1973
- 1973-11-05 GB GB5132473A patent/GB1454105A/en not_active Expired
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2400904A1 (en) * | 1977-08-24 | 1979-03-23 | Takeda Chemical Industries Ltd | PREPARATIONS FOR VAGINAL ADMINISTRATION AND THEIR USE AS AGENTS CAUSING OVULATION OR AS ANTI-MITOTIC AGENTS |
US5116817A (en) * | 1982-12-10 | 1992-05-26 | Syntex (U.S.A.) Inc. | LHRH preparations for intranasal administration |
EP0111841A1 (en) * | 1982-12-10 | 1984-06-27 | Syntex (U.S.A.) Inc. | LHRH preparations for intranasal administration |
US4476116A (en) * | 1982-12-10 | 1984-10-09 | Syntex (U.S.A.) Inc. | Polypeptides/chelating agent nasal compositions having enhanced peptide absorption |
US5411951A (en) * | 1984-10-04 | 1995-05-02 | Monsanto Company | Prolonged release of biologically active somatotropin |
US5013713A (en) * | 1984-10-04 | 1991-05-07 | Monsanto Company | Prolonged release of biologically active somatotropin |
US5086041A (en) * | 1984-10-04 | 1992-02-04 | Monsanto Company | Methods of using prolonged release somatotropin compositions |
US4985404A (en) * | 1984-10-04 | 1991-01-15 | Monsanto Company | Prolonged release of biologically active polypeptides |
US5474980A (en) * | 1984-10-04 | 1995-12-12 | Monsanto Company | Prolonged release of biologically active somatotropins |
US5595971A (en) * | 1984-10-04 | 1997-01-21 | Monsanto Company | Prolonged release of biologically active polypeptides |
US4897256A (en) * | 1986-11-25 | 1990-01-30 | Abbott Laboratories | LHRH analog formulations |
US5618786A (en) * | 1987-04-30 | 1997-04-08 | Cooper Laboratories, Inc. | Aerosolization of protein therapeutic agent |
FR2673635A1 (en) * | 1990-11-09 | 1992-09-11 | Egyt Gyogyszervegyeszeti Gyar | PROCESS FOR THE PREPARATION OF AEROSOL COMPOSITION |
CN1109558C (en) * | 1993-06-29 | 2003-05-28 | 凡林有限公司 | Stabilized pharmaceutical peptide compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1454105A (en) | Preparation containing luteinizing hormone-releasing factor | |
ES8308698A1 (en) | Topical pharmaceutical compositions | |
IE33672B1 (en) | Bis-basic ethers and thioethers of fluorenone,fluorenol and fluorene | |
GB1256723A (en) | ||
GB1457546A (en) | Pharmaceutical preparations comprising cephalosporin derivatives | |
GB1363047A (en) | Pyrimidine derivative process for its preparation and its use as a medicament | |
GB1270049A (en) | New pharmaceutical product | |
IE33230B1 (en) | Anti-haemorrhoidally active preparations for local or rectal administration | |
GB1296133A (en) | ||
GB1298587A (en) | Methods of contraception and contraceptive compositions | |
DE69419910D1 (en) | OXYTOCINANTAGONIST | |
IE34609B1 (en) | Antineoplastic therapeutic compositions | |
GB1100295A (en) | Cosmetic preparations for hair-nourishing or hair-growing | |
GB1465771A (en) | Pharmaceutical composition and use thereofd | |
GB1460058A (en) | Pharmacologically active substances obtainable from cadia ellisiana | |
GB1342540A (en) | Sulphonic acid esters their preparation and their medicinal use | |
GB1324300A (en) | Antifungal thiocyanatobenzothiazoles | |
GB1239467A (en) | ||
GB1168302A (en) | Aluminium N-Acetylglycinate and Pharmaceutical Compositions containing the same | |
GB1279380A (en) | Improvements in or relating to hydantoins and compositions thereof | |
GB1152677A (en) | Improved Anabolic Agent | |
IE37288L (en) | Crane assembly | |
GB1317099A (en) | 3-sulphamyl-4-chlorobenzoic acid derivatives | |
GB1253752A (en) | A non-depolarising curariform pharmaceutical preparation | |
GB1223548A (en) | Fluorene-derived sulphones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PCNP | Patent ceased through non-payment of renewal fee |